- Home
- TRIP vs OLMA Comparison
TRIP vs OLMA Comparison
Compare TRIP & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRIP | OLMA |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2011 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TRIP | OLMA |
|---|---|---|
| Price | $9.66 | $10.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 10 |
| Target Price | $14.40 | ★ $44.89 |
| AVG Volume (30 Days) | ★ 3.7M | 951.7K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 675.00 | 15.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,556,000,000.00 | N/A |
| Revenue This Year | $3.33 | N/A |
| Revenue Next Year | $5.12 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.01 | $5.36 |
| 52 Week High | $20.16 | $36.26 |
Technical Indicators
Market Signals| Indicator | TRIP | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 29.73 | 47.09 |
| Support Level | $9.54 | $10.71 |
| Resistance Level | $11.76 | $11.36 |
| Average True Range (ATR) | 0.40 | 0.51 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 1.01 | 48.50 |
Price Performance
Historical ComparisonAbout TRIP TripAdvisor Inc.
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, experiences, airlines, and cruises. In 2025, 42% of revenue came from the company's core Hotel and Other segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of revenue in 2025. The company is selling TheFork, its dining brand, which represented 12% of sales.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.